Endocrine Pharmacology Practice Questions

Q: Which of the following oral antidiabetic drugs is an insulin secretagogue?

Nateglinide. **Nateglinide** - **Nateglinide** is a **meglitinide**, which is a type of **insulin secretagogue**. - It stimulates **insulin release** from pancreatic beta cells by blocking ATP-sensitive potassium channels. *Metformin* - **Metformin** is a **biguanide** that primarily works by **decreasing hepatic glucose production** and increasing insulin sensitivity in peripheral tissues. - It does not directly stimulate insulin secretion. *Pioglitazone* - **Pioglitazone** is a **thiazolidinedione** (TZD) that improves insulin sensitivity by activating **PPAR-gamma receptors**. - It does not directly affect insulin secretion but rather enhances the body's response to existing insulin. *Acarbose* - **Acarbose** is an **alpha-glucosidase inhibitor** that delays the digestion and absorption of carbohydrates in the small intestine. - This reduces postprandial glucose excursions and does not directly stimulate insulin secretion.

Q: A patient has Cushing syndrome due to an adrenal tumor. Which drug should be given?

Ketoconazole. ***Ketoconazole*** - **Ketoconazole** is an antifungal agent that also inhibits several enzymes involved in **steroidogenesis**, including 17α-hydroxylase and 11β-hydroxylase. - This action helps to reduce the overproduction of **cortisol** in Cushing syndrome caused by an adrenal tumor. *Hydrocortisone* - **Hydrocortisone** is a glucocorticoid itself and would exacerbate the symptoms of **Cushing syndrome** by adding to the already elevated cortisol levels. - It is used for **cortisol replacement therapy** in conditions like Addison's disease, where cortisol levels are low. *Dexamethasone* - **Dexamethasone** is a potent synthetic glucocorticoid used to suppress **ACTH production** in cases of ACTH-dependent Cushing's syndrome (e.g., Cushing's disease) or to diagnose Cushing's syndrome. - In an adrenal tumor, which is **ACTH-independent**, dexamethasone would not reduce cortisol production but could instead worsen the hypercortisolism. *Spironolactone* - **Spironolactone** is an **aldosterone antagonist** and a weak antiandrogen, primarily used for conditions like hyperaldosteronism, heart failure, and hirsutism. - It has no direct effect on the overproduction of **cortisol** from an adrenal tumor in Cushing syndrome.

Q: Which drug is commonly used to treat hyperprolactinemia in women experiencing infertility?

Bromocriptine. ***Bromocriptine*** - **Bromocriptine** is a **dopamine agonist** that directly inhibits **prolactin secretion** from the pituitary gland. - By lowering prolactin levels, it helps restore **ovulatory function** and **fertility** in women with hyperprolactinemia. - It is the **first-line treatment** for hyperprolactinemia-induced infertility. *Gonadotropin-Releasing Hormone (GnRH)* - **GnRH** (or its agonists/antagonists) is primarily used to control **gonadotropin release** for conditions like **endometriosis** or **fibroids**, or in **assisted reproductive technologies**. - It does not directly treat hyperprolactinemia by inhibiting prolactin secretion. *Testosterone (Androgen)* - **Testosterone** is an **androgen** and is generally not used in women for infertility, especially not for hyperprolactinemia. - High testosterone levels in women can cause **hirsutism** and **anovulation**, which would worsen infertility. *Corticosteroids* - **Corticosteroids** are potent **anti-inflammatory** and **immunosuppressive** agents. - They are used to treat various autoimmune conditions or inflammation but have no direct role in treating hyperprolactinemia or female infertility in this context.

Q: What is the drug of choice for pheochromocytoma?

Phenoxybenzamine. ***Phenoxybenzamine*** - This is an **irreversible, non-selective alpha-adrenergic blocker**, which is the drug of choice for preparing patients for surgical removal of a pheochromocytoma. - It effectively controls **hypertension** by blocking the effects of catecholamines on blood vessels, preventing a hypertensive crisis during surgery. *Propranolol* - **Beta-blockers** like propranolol should **not be used as monotherapy** in pheochromocytoma because blocking beta-2 receptors without prior alpha blockade can lead to unopposed alpha-adrenergic vasoconstriction and precipitate a **hypertensive crisis**. - It can be added **after adequate alpha-blockade** to control tachycardia. *Prazosin* - Prazosin is a **reversible, selective alpha-1 adrenergic blocker**, which is not preferred over phenoxybenzamine due to its shorter duration of action and reversibility. - While it can lower blood pressure, its efficacy in preventing hypertensive crises during surgery for pheochromocytoma is **less robust** compared to phenoxybenzamine. *Nitroprusside* - Sodium nitroprusside is a **potent vasodilator** often used for **hypertensive emergencies**, but it is not the drug of choice for long-term management or preoperative preparation in pheochromocytoma. - Its use in pheochromocytoma is typically reserved for **acute hypertensive crises** when other agents are insufficient, rather than initial management.

Q: Which of the following drugs can cause thyroid dysfunction?

Amiodarone. ***Amiodarone*** - **Amiodarone** is known to cause both **hypothyroidism** and **hyperthyroidism** due to its high iodine content and direct toxic effects on the thyroid gland. - Its effects can persist for months after discontinuation due to its **long half-life** and accumulation in tissues. *Ampicillin* - **Ampicillin** is an antibiotic that generally does not directly affect thyroid function. - Its primary mechanism of action involves inhibiting **bacterial cell wall synthesis**, with no known significant endocrine side effects. *Ibutilide* - **Ibutilide** is an antiarrhythmic drug used for recent-onset atrial fibrillation or flutter. - It works by blocking potassium channels and has no recognized association with thyroid dysfunction. *Acyclovir* - **Acyclovir** is an antiviral medication used to treat herpes virus infections. - Its mechanism of action involves inhibiting viral DNA replication and it is not known to impact thyroid hormone synthesis or metabolism.

Q: Which of the following statements about sitagliptin is false?

Cannot be used orally. ***Cannot be used orally*** - This statement is **false** because **sitagliptin** is an **oral medication** approved for the treatment of type 2 diabetes mellitus. - As a **DPP-4 inhibitor**, it is designed to be taken by mouth to increase incretin hormone levels. *Used in type II diabetes mellitus* - This statement is **true** as **sitagliptin** is a commonly prescribed **oral antidiabetic drug** for the management of type 2 diabetes. - It works by inhibiting the enzyme **dipeptidyl peptidase-4 (DPP-4)**, which increases levels of **GLP-1** and **GIP** to enhance insulin secretion and reduce glucagon secretion. *Used in combination with other oral hypoglycemic agents* - This statement is **true** as **sitagliptin** is often used as **add-on therapy** with other oral hypoglycemic agents like **metformin** or a **sulfonylurea** when monotherapy is insufficient. - This combination approach helps achieve better glycemic control by targeting different mechanisms of action. *All of the above statements are true* - This statement is **false** because the first statement "Cannot be used orally" is incorrect. - Since sitagliptin is indeed an oral medication, not all the above statements are true, making this option incorrect.

Q: What conditions is Metformin primarily used to treat?

Both Type 2 Diabetes and Polycystic Ovary Syndrome (PCOS). ***Both Type 2 Diabetes and Polycystic Ovary Syndrome (PCOS)*** - **Metformin** is a first-line treatment for **Type 2 Diabetes** due to its ability to decrease hepatic glucose production and improve insulin sensitivity [1], [2]. - It is also commonly used off-label for **PCOS** to improve insulin resistance, ovulation, and reduce androgen levels. *Only Type 2 Diabetes* - While Metformin is a cornerstone for **Type 2 Diabetes** treatment, stating "only" is incorrect as it has other significant therapeutic uses [2]. - Its benefits extend beyond diabetes management, particularly in conditions involving **insulin resistance**. *Only Polycystic Ovary Syndrome (PCOS)* - Metformin is used in **PCOS**, but it is not the sole condition it treats, and its primary indication remains **Type 2 Diabetes** [2]. - This option incorrectly limits its application to just one condition, overlooking its major role in diabetes. *Pregnancy Induced Hypertension* - **Metformin** is not indicated for the treatment of **pregnancy-induced hypertension** (gestational hypertension). - Treatment for pregnancy-induced hypertension typically involves medications like **labetalol**, **methyldopa**, or **nifedipine**, with delivery being the definitive management for severe cases.

Q: Which of the following is the longest acting glucocorticoid?

Dexamethasone. ***Correct: Dexamethasone*** - **Dexamethasone** is a long-acting glucocorticoid with a **biological half-life of 36–72 hours**, making it the longest acting among the options provided - Its prolonged action is due to its **high affinity for the glucocorticoid receptor** and relatively slow metabolism - Provides sustained anti-inflammatory and immunosuppressive effects *Incorrect: Prednisone* - **Prednisone** is an intermediate-acting glucocorticoid with a biological half-life of 12-36 hours - Requires metabolism in the liver to its active form, prednisolone - Duration of action is significantly shorter than dexamethasone *Incorrect: Prednisolone* - **Prednisolone** is the active form of prednisone, with a similar intermediate duration of action (12-36 hours) - Primarily used when liver conversion of prednisone is impaired - Does not possess the extended duration of action characteristic of dexamethasone *Incorrect: Cortisone* - **Cortisone** is a short-acting glucocorticoid with a biological half-life of 8-12 hours - It is a prodrug that needs to be converted to **hydrocortisone** (cortisol) in the liver to become active - Has the shortest duration among all options

Q: Which of the following antidiabetic drugs (other than insulin) is indicated as adjunct therapy for the management of both type I and type II diabetes mellitus?

Pramlintide. Pramlintide - Pramlintide is an amylin analog indicated as an adjunct therapy to insulin for both type 1 and type 2 diabetes, helping to regulate post-prandial glucose. - It slows gastric emptying, suppresses postprandial glucagon secretion, and promotes satiety, leading to reduced insulin requirements and improved glycemic control. Sulphonylureas - Sulphonylureas primarily stimulate insulin secretion from pancreatic beta cells, making them effective only in Type 2 diabetes where some beta-cell function is preserved [2]. - They are not indicated for Type 1 diabetes because these patients have absolute insulin deficiency due to beta cell destruction. Metformin - Metformin is a biguanide that primarily reduces hepatic glucose production and improves insulin sensitivity in peripheral tissues. - It is a first-line treatment for Type 2 diabetes but is generally not used for Type 1 diabetes as it does not address the fundamental lack of insulin. Acarbose - Acarbose is an alpha-glucosidase inhibitor that works by delaying carbohydrate absorption from the gastrointestinal tract, thus reducing postprandial glucose spikes [1]. - While it can be used in Type 2 diabetes to manage postprandial hyperglycemia, it is not typically indicated as an adjunct for Type 1 diabetes alongside insulin [3].

Question 1

Which of the following oral antidiabetic drugs is an insulin secretagogue?

Accepted Answer

Nateglinide

Answer

Metformin

Answer

Pioglitazone

Answer

Acarbose

Question 2

Which of the following statements about Selective Estrogen Receptor Modulators (SERMs) is correct?

Accepted Answer

Some SERMs can act as both agonists and antagonists on estrogen receptors.

Answer

Act as agonists on estrogen receptors.

Answer

Used to reduce the risk of hot flushes and thromboembolism.

Answer

Act as antagonists on estrogen receptors.

Question 3

A patient has Cushing syndrome due to an adrenal tumor. Which drug should be given?

Accepted Answer

Ketoconazole

Answer

Spironolactone

Answer

Hydrocortisone

Answer

Dexamethasone

Question 4

Which drug is commonly used to treat hyperprolactinemia in women experiencing infertility?

Accepted Answer

Bromocriptine

Answer

Gonadotropin-Releasing Hormone (GnRH)

Answer

Testosterone (Androgen)

Answer

Corticosteroids

Question 5

What is the drug of choice for pheochromocytoma?

Accepted Answer

Phenoxybenzamine

Answer

Propranolol

Answer

Prazosin

Answer

Nitroprusside

Question 6

Which of the following drugs can cause thyroid dysfunction?

Accepted Answer

Amiodarone

Answer

Ampicillin

Answer

Ibutilide

Answer

Acyclovir

Question 7

Which of the following statements about sitagliptin is false?

Accepted Answer

Cannot be used orally

Answer

Used in type II diabetes mellitus

Answer

Used in combination with other oral hypoglycemic agents

Answer

All of the above statements are true

Question 8

What conditions is Metformin primarily used to treat?

Accepted Answer

Both Type 2 Diabetes and Polycystic Ovary Syndrome (PCOS)

Answer

Only Type 2 Diabetes

Answer

Only Polycystic Ovary Syndrome (PCOS)

Answer

Pregnancy Induced Hypertension

Question 9

Which of the following is the longest acting glucocorticoid?

Accepted Answer

Dexamethasone

Answer

Prednisone

Answer

Prednisolone

Answer

Cortisone

Question 10

Which of the following antidiabetic drugs (other than insulin) is indicated as adjunct therapy for the management of both type I and type II diabetes mellitus?

Accepted Answer

Pramlintide

Answer

Sulphonylureas

Answer

Metformin

Answer

Acarbose

Endocrine Pharmacology — MCQs

Endocrine Pharmacology — MCQs

On this page

Practice by Chapter

Want unlimited practice?